• NeoGenomics Nabs Human Longevity's Oncology Division for $37M

    12 days ago - By Xconomy

    The genetic testing company NeoGenomics has acquired Human Longevity's Oncology Division, which provides next-generation sequencing services. The division of San Diego-based Human Longevity generated approximately $10 million in revenue in 2019-an amount NeoGenomics thinks it can grow by nearly 50 percent, says Charlie Eidson, investor relations and corporate development analyst, NeoGenomics. Additionally, the oncology division closed out the year with a backlog of approximately $15 million worth of signed contracts. According to Eidson, the deal boosts NeoGenomics's pharma services and...
    Read more ...